Phytosomes: Bridging Herbal Medicine And Modern Drug Delivery Technology
Abstract
Phytosomes are novel phospholipid drug delivery mechanisms that enhance absorption, bioavailability and therapeutic efficacy of plant-derived bioactive constituents. Herbal medications include multiple pharmacologically active phytoconstituents but their clinical efficacy may be hindered by their low water solubility, limited intestinal permeability, chemical instability and substantial first-pass metabolism. Phytosome technology overcomes these problems via the formation of molecular complexes of phospholipids, especially phosphatidylcholine and standardized plant extracts or separated phytoconstituents. Such complexes may improve the interactions with biological membranes and the transport of certain phytochemicals. Phytosomes are gaining significant attention of the researchers for their possible role in the treatment of inflammatory illnesses, liver disorders, cardiovascular diseases, metabolic disorders, skin diseases and cancer. They are also being studied for use in nutraceuticals, cosmetics, and topical formulations. This review speaks about the basic concepts, formulation strategies, latest research, benefits, drawbacks, limits and therapeutic uses of phytosomes. Formulation characterisation, stability, manufacturing problems, safety and clinical translation are all discussed in detail. Despite encouraging experimental and some clinical data, the advantages of phytosomes rely on the phytoconstituent, composition of the formulation and the mode of administration. More standardized research, large-scale manufacturing studies, and well-designed clinical trials are needed to determine their long-term safety, effectiveness, and commercial viability. Phytosomes provide a viable approach to combine traditional herbal treatment and current pharmaceutical technologies.
Downloads
References
2. Riaz M, Khalid R, Afzal M, Anjum F, Fatima H, Zia S, Rasool G, Egbuna C, Mtewa AG, Uche CZ, Aslam MA. Phytobioactive compounds as therapeutic agents for human diseases: A review. Food science & nutrition. 2023;11(6):2500-29.
3. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine. 2002;9:1-33.
4. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. Journal of pharmaceutical sciences. 1993;82(10):979-87.
5. Shree JN, Anuf AR, Ahmad S. Comparative analysis of traditional and nano-formulated approaches in viability, targeted delivery, and patient outcomes. InHerbal pharmacopeia. CRC Press, 2025, pp. 375-392.
6. Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81(7):680-9.
7. Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, Gangadharappa HV, Pardakhty A, Mehrbani M, Dell'Agli M, Nematollahi MH. Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature. Int J Nanomedicine. 2021;16:6983-7022.
8. Khan J, Alexander A, Saraf S, Saraf S. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. Journal of controlled release. 2013;168(1):50-60.
9. Alharbi WS, Almughem FA, Almehmady AM, Jarallah SJ, Alsharif WK, Alzahrani NM, Alshehri AA. Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics. 2021;13(9):1475.
10. Tsuchiya H. Membrane interactions of phytochemicals as their molecular mechanism applicable to the discovery of drug leads from plants. Molecules. 2015;20(10):18923-66.
11. Hollmann A, Martinez M, Maturana P, Semorile LC, Maffia PC. Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics. Frontiers in chemistry. 2018;6:204.
12. Matias D, Rijo P, Pinto Reis C. Phytosomes as biocompatible carriers of natural drugs. Current Medicinal Chemistry. 2017;24(6):568-89.
13. Lu M, Qiu Q, Luo X, Liu X, Sun J, Wang C, Lin X, Deng Y, Song Y. Phyto-phospholipid complexes (phytosomes): A novel strategy to improve the bioavailability of active constituents. Asian journal of pharmaceutical sciences. 2019;14(3):265-74.
14. Chiu YH, Wu YW, Hung JI, Chen MC. Epigallocatechin gallate/L-ascorbic acid–loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis. Acta Biomaterialia. 2021;130:223-33.
15. Koppula S, Shaik B, Maddi S. Phytosomes as a new frontier and emerging nanotechnology platform for phytopharmaceuticals: therapeutic and clinical applications. Phytotherapy Research. 2025;39(5):2217-49.
16. Thakur S, Gautam T, Sharma D. Phytosomes in Metabolic Disorders: Advancement and Innovative Approaches in Drug Delivery Systems. Mini-Reviews in Medicinal Chemistry. 2026.
17. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14(3):226-46.
18. Toma L, Deleanu M, Sanda GM, Barbălată T, Niculescu LŞ, Sima AV, Stancu CS. Bioactive compounds formulated in phytosomes administered as complementary therapy for metabolic disorders. International Journal of Molecular Sciences. 2024;25(8):4162.
19. Mehmood H. Phytosome as a novel carrier for delivery of phytochemicals: a comprehensive review. Middle east journal of applied science & technology. 2023;6(4):21-51.
20. Chaudhary K, Rajora A. Phytosomes: a critical tool for delivery of herbal drugs for cancer: Phytosomes: Advancing Herbal Medicine Delivery. Phytochemistry reviews. 2025;24(1):165-95.
21. Gaikwad SS, Morade YY, Kothule AM, Kshirsagar SJ, Laddha UD, Salunkhe KS. Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook. Heliyon. 2023;9(6):e16561.
22. Priya VM, Kumaran A. Recent trends in phytosome nanocarriers for improved bioavailability and uptake of herbal drugs. Pharmaceutical Sciences. 2023;29(3):298-319.
23. Kamini, Puri D. Phytosome: A Cutting-edge Approach for Augmenting the Delivery of Phyto-pharmaceuticals. Current Drug Research Reviews. 2025.
24. Mane K, Baokar S, Bhujbal A, Pharande S, Patil G, Patil R, Jain P, Pandey A. Phyto-phospholipid complexes (phytosomes): a novel approach to improve the bioavailability of active constituents. Journal of Advanced Scientific Research. 2020;11(03):68-78.
25. Mysore Ismail MA, Dubey A, Shetty A, Perumalsamy H, Balusamy SR, Lee S, Mahadev M. Phytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation. Pharmaceutics. 2026;18(10):1232.
26. Agarwal A, Chakraborty P, Chakraborty DD, Saharan VA. Phytosomes: complexation, utilisation and commerical status. Journal of Biologically Active Products from Nature. 2012;2(2):65-77.
27. Sergazy S, Aliakpar S, Adekenova G, Itzhanova K, Taglialatela-Scafati O, Adekenov S. Terpenoid phytosomes as advanced delivery systems: molecular interactions, pharmacological potential, and scalable manufacturing approaches. International Journal of Molecular Sciences. 2026;27(6):2868.
28. Khabarov IA, Sergazy SD, Amanzhan A, Maikenova AS, Zhabayeva AN, Adekenov SM. Polyphenolic phytosomes for targeted drug delivery. Fitoterapia. 2025;187:106920.
29. Bhattacharya S. Phytosomes: the new technology for enhancement of bioavailability of botanicals and nutraceuticals. International Journal of Health Research. 2009;2(3):225-32.
30. Puglia C, Lauro MR, Tirendi GG, Fassari GE, Carbone C, Bonina F, Puglisi G. Modern drug delivery strategies applied to natural active compounds. Expert Opinion on Drug Delivery. 2017;14(6):755-68.
31. Riva A, Ronchi M, Petrangolini G, Bosisio S, Allegrini P. Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin: A. Riva et al. European journal of drug metabolism and pharmacokinetics. 2019;44(2):169-77.
32. Amin T, Bhat SV. A review on phytosome technology as a novel approach to improve the bioavailability of nutraceuticals. Int. J. Adv. Res. Technol. 2012;1(3):43-57.
33. Karpuz M, Gunay MS, Ozer AY. Liposomes and phytosomes for phytoconstituents. InAdvances and avenues in the development of novel carriers for bioactives and biological agents. Academic Press. 2020; pp. 525-553.
34. Ghanbarzadeh B, Babazadeh A, Hamishehkar H. Nano-phytosome as a potential food-grade delivery system. Food bioscience. 2016;15:126-35.
35. Patel J, Patel R, Khambholja K, Patel N. An overview of phytosomes as an advanced herbal drug delivery system. Asian J Pharm Sci. 2009;4(6):363-71.
36. Mohare A, Meti V, Guddad A, Harish KH, Dasankoppa F. Herbal phytosomal gels: benefits, challenges, and future directions: a review. IP Int J Compr Adv Pharmacol. 2025;10(1):3-15.
37. Loguercio C, Festi D. Silybin and the liver: from basic research to clinical practice. World Journal of Gastroenterology. 2011;17(18):2288.
38. Kumar S, Alsaidan OA, Alzarea SI, Kumar A, Kondaveeti SB, Sharma D, Kumar M, Kumar D. Integrating quality by design (QbD) in phytosomal drug delivery: A new era in precision phytotherapy. AAPS PharmSciTech. 2025;26(7):198.
39. Mukhopadhyay S, AgrawalN, BiswasJ, Bharat V, Lanjhiyana SK, Bharti SK,Jaiswal M. Phytosome-based drug delivery systems: an updated patent review. Phytochemistry Reviews. 2026;25:5027-58.
40. Damera S, Kuchukuntla M, Sharma M, Manda RM, Chettupalli AK, Jadi RK. Novel phytosomal drug delivery systems in cancer therapy: advances, mechanisms, and translational potential. Journal of Applied Pharmaceutical Research. 2026;14(3):18-35.
41. Ganesan P, Choi DK. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy. International Journal of Nanomedicine. 2016;11:1987-2007.
42. Abuelella KE, Salem AY. Advanced nanocarrier-based strategies for enhancing herbal actives in cosmetic and cosmeceutical applications. Nanotechnology and Applied Sciences Journal. 2025;1(2):23-43.
43. Deniz FS, Tuğcu Demiröz FN, Ulutaş OK, Orhan IE. Phytosomes-Unraveling the Unique Properties of Plant-Derived Nanotechnological Drug Delivery Systems: A Review. Current Medicinal Chemistry. 2025;32(15):3088-105.
44. KS S, Aditi K. Phytosome as a novel drug delivery system for bioavailability enhancement of phytoconstituents and its applications: A review. Journal of Drug Delivery & Therapeutics. 2021;11(3):138.
45. Yadav AK, Kamal R, Agarwal V, Sharma PK. Phytosomes: advancing herbal medicine through innovative integration. Current Pharmaceutical Design. 2025;31(42):3390-9.
46. Maryana W, Rachmawati H, Mudhakir D. Formation of phytosome containing silymarin using thin layer-hydration technique aimed for oral delivery. Materials today: proceedings. 2016;3(3):855-66.
47. Vinukonda A, Bolledla N, Jadi RK, Chinthala R, Devadasu VR. Synthesis of nanoparticles using advanced techniques. Next Nanotechnol, 2025;8:100169.
48. Zuccari G, Alfei S. Development of phytochemical delivery systems by nano-suspension and nano-emulsion techniques. International Journal of Molecular Sciences. 2023;24(12):9824.
49. Chettupalli AK, Kakkerla A, Jadi RK, Uppu P, Ghazwani M, Hani U, Amarachinta PR, Sarvani P, Haque MA. Design, development, and preclinical evaluation of pirfenidone-loaded nanostructured lipid carriers for pulmonary delivery. Scientific Reports. 2025;15(1):11390.
50. Avula PR, Chettupalli AK, Chauhan V, Jadi RK. Design, formulation, in-vitro and in-vivo pharmacokinetic evaluation of Nicardipine-nanostructured lipid carrier for transdermal drug delivery system. Materials today: Proceedings. 2023.
51. Chettupalli AK, Ajmera S, Amarachinta PR, Manda RM, Jadi RK. Quality by Design approach for preparation, characterization, and statistical optimization of naproxen sodium-loaded ethosomes via transdermal route. Current bioactive compounds. 2023;19(10):79-98.
52. Chettupalli AK, Unnisa A, Peddapalli H, Jadi RK, Anusha K, Amarachinta PR. Development and evaluation of empagliflozin-loaded solid lipid nanoparticles: Pharmacokinetics and pharmacodynamics for oral delivery. Intelligent pharmacy. 2025;3(3):193-206.
53. Prasad RR, Kumar JR, Vasudha BA, Kumar CA. Formulation development and evaluation of allopurinol solid dispersions by solvent evaporation technique. Int J Appl Pharm. 2018;10(4):168-71.
54. Sapavatu SN, Jadi RK. Formulation development and characterization of gastroretentive drug delivery systems of loratadine. International journal of applied pharmaceutics. 2019;11(6):91-9.
55. Eslavath RN, Bakshi V, Jadi RK. Formulation Development and In Vitro Release Studies of Tenofovir-containing Microsponges. INNOSC Theranostics and pharmacological sciences. 2019;2(2):16-24.
56. Vinukonda A, Rapolu K, Jadi RK, Devadasu VR. Complex peptide injectables: development and challenges. International Journal of Peptide Research and Therapeutics. 2025;31(3):51.
57. Sharaff CS, Renukuntla P, Peddapalli H, Kuchukuntla M, Bakshi V, Jadi RK. Formulation, development, and characterization of loratadine emulgel. Journal of applied pharmaceutical research. 2024;12(2):42-50.
58. Sapavatu SN, Chinthala R, Jadi RK. An overview on Pharmacokinetics of Polymeric Nanoparticles Intended for Oral Delivery. Journal of Young Pharmacists. 2020;12(3):187.
59. Pandala S, Bakshi V, Jadi RK. Formulation development and in vitro characterization of zolmitriptan controlled release drug delivery systems. INNOSC Theranostics Pharmacol. Sci. 2019;2(1):6-11.
60. Sapavatu SN, Jadi RK. Development of floating drug delivery system for loratadine: in vitro and in vivo evaluation. International journal of pharmaceutical sciences and research. 2020;11:3021-2.
61. Komati S, Dasi V, Jadi RK, Padala NR. Formulation Development and Characterization of Atazanavir Sulphate Controlled Release Non-Effervescent Floating Matrix Tablets. Journal of Drug Delivery & Therapeutics. 2019;9(4A):601.
62. Togaru V, Venisetty RK, Bakshi V, Jadi RK. Formulation Development and In Vitro Evaluation of Propranolol Hydrochloride Extended Release Matrix Tablets. Emergent life sciences research. 2017;3:38-47.
63. Jadi RK, Tatikonda A, Veera Reddy PR, Venisetty RK. Design and characterization of pregabalin swellable core osmotic pumps. Int J Pharm Res Allied Sci. 2016;5(3):8–15.
64. Chauhan M, Rani A, Mazumder R, Mishra R. Bridging the Gap Between Nanocarrier Research and Regulatory Approval: A Focus on Phytosomes. Journal of Chemical Health Risks. 2026;16(3):1228.
65. Chettupalli AK, Bukke SPN, Babu MR, Amarachinta PR, Boggula N, Mohammed A. Mucoadhesive lyophilized wafers loaded with nano-spanlastic felodipine formulation: development and characterization. Sci Rep. 2025;15(1):39037.
66. Vijayavani S Ch, Dr. Narender B, Sadhana K, Pallavi K, Sudha Bhargavi Ch. Mechanism, Advancement, Challenges, and Future Prospects for Enhanced Anticancer Efficacy by Phytosomes. Sustainability in Agricultural Production Systems, Adam’s Book Company, Maharashtra, 2025, pp. 1-22.
67. Himabindu P, Rajendra Prasad G, Narender B. Formulation and Evaluation of Transdermal Patches for Antianxiety Drug. Asian Journal of Pharmaceutics. 2018;12(2):127-36.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.

.